Free Trial

Prestige Consumer Healthcare (PBH) Earnings Date, Estimates & Call Transcripts

Prestige Consumer Healthcare logo
$87.07 +0.03 (+0.03%)
As of 12:48 PM Eastern

Prestige Consumer Healthcare Earnings Summary

Prestige Consumer Healthcare released Q4 2025 earnings on May 8, 2025, reporting an EPS of $1.32, which beat analysts' consensus estimates of $1.30 by $0.02. Quarterly revenue rose 7.0% year-over-year to $296.52 million, above analyst estimates of $289.36 million. With a trailing EPS of $4.27 and a P/E Ratio of 20.39, Prestige Consumer Healthcare's earnings are expected to grow 5.78% next year, from $4.50 to $4.76 per share.

Latest Q4
Earnings Date
May. 8Estimated
Consensus EPS
(May. 8)
$1.30
Actual EPS
(May. 8)
$1.32 Beat By $0.02
Actual Revenue
(May. 8)
$296.52M

Q4 2025 Earnings Resources

Get Prestige Consumer Healthcare Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Prestige Consumer Healthcare and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

PBH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PBH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Prestige Consumer Healthcare Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue Guidance
Q1 20253$0.86$0.86$0.86
Q2 20253$1.08$1.09$1.08
Q3 20253$1.16$1.21$1.19
Q4 20253$1.30$1.30$1.30
FY 2025 12 $4.40 $4.46 $4.43
Q1 20261$0.97$0.97$0.97
Q2 20261$1.16$1.16$1.16
Q3 20261$1.26$1.26$1.26
Q4 20261$1.37$1.37$1.37
FY 2026 4 $4.76 $4.76 $4.76
Q1 20271$1.11$1.11$1.11
Q2 20271$1.21$1.21$1.21
Q3 20271$1.29$1.29$1.29
Q4 20271$1.42$1.42$1.42

Prestige Consumer Healthcare Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/8/2025Q4 2025$1.30$1.32+$0.02$1.00$289.36M$296.52M
2/6/2025Q3 2025$1.18$1.22+$0.04$1.22$287.07M-
11/7/2024Q2 2025$1.09$1.09-$1.09$282.09M$283.79M
8/8/2024Q1 2025$0.86$0.90+$0.04$0.82$260.54M$267.10M
5/14/2024Q4 2024$1.14$1.02 -$0.12$1.06$287.42M$277.00M
2/8/2024Q3 2024$1.04$1.06+$0.02$1.06$280.25M$282.74M
11/2/2023Q2 2024$1.07$1.07-$1.07$285.13M$286.32M
8/3/2023Q1 2024$1.01$1.06+$0.05$1.06$278.79M$279.31M

Prestige Consumer Healthcare Earnings - Frequently Asked Questions

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earning data on Thursday, May 8, 2025. Learn more on PBH's earnings history.

Prestige Consumer Healthcare updated its FY 2026 earnings guidance on Thursday, May, 8th. The company provided earnings per share (EPS) guidance of 4.700-4.820 for the period, compared to the consensus EPS estimate of 4.790. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion.

In the previous quarter, Prestige Consumer Healthcare (NYSE:PBH) reported $1.32 earnings per share (EPS) to beat the analysts' consensus estimate of $1.30 by $0.02. Learn more on analysts' earnings estimate vs. PBH's actual earnings.

The conference call for Prestige Consumer Healthcare's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Prestige Consumer Healthcare's latest earnings report can be read online.
Read Transcript

Prestige Consumer Healthcare's earnings report can be found in their filing with the SEC.
View SEC filing

Prestige Consumer Healthcare (NYSE:PBH) has a recorded annual revenue of $1.12 billion.

Prestige Consumer Healthcare (NYSE:PBH) has a recorded net income of $209.34 million. PBH has generated $4.27 earnings per share over the last four quarters.

Prestige Consumer Healthcare (NYSE:PBH) has a trailing price-to-earnings ratio of 20.17 and a forward price-to-earnings ratio of 19.14. The price/earnings-to-growth ratio is 2.69.

Prestige Consumer Healthcare's earnings are expected to grow from $4.50 per share to $4.76 per share in the next year, which is a 5.78% increase.

More Earnings Resources from MarketBeat



This page (NYSE:PBH) was last updated on 5/9/2025 by MarketBeat.com Staff
From Our Partners